XML 43 R4.htm IDEA: XBRL DOCUMENT v3.2.0.727
Condensed Consolidated Statements of Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Net sales $ 506,102 $ 536,832 $ 978,923 $ 1,046,176
Cost of goods sold 226,505 239,590 429,220 473,645
Gross profit 279,597 297,242 549,703 572,531
Selling, general and administrative expense 192,845 195,838 381,400 398,113
Research and Development Expense 46,547 55,717 93,749 108,260
Segment profit (loss) 40,205 45,687 74,554 66,158
Interest expense 4,834 5,564 9,836 9,421
Foreign exchange losses, net 2,938 (286) 6,744 2,451
Other (income) expense, net (7,107) (8,388) (8,260) (9,049)
Income before income taxes 39,540 48,797 66,234 63,335
Provision for income taxes (11,117) (17,166) (19,993) (25,036)
Net income including noncontrolling interests 28,423 31,631 46,241 38,299
Net income attributable to Bio-Rad $ 28,423 $ 31,631 $ 46,241 $ 38,299
Basic earnings per share:        
Net income per share basic attributable to Bio-Rad $ 0.98 $ 1.10 $ 1.59 $ 1.33
Weighted average common shares - basic 29,136 28,826 29,114 28,809
Diluted earnings per share:        
Net income per share diluted attributable to Bio-Rad $ 0.97 $ 1.09 $ 1.58 $ 1.32
Weighted average common shares - diluted 29,381 29,092 29,338 29,076